Verastem, Inc. (VSTM): Total Liabilities
$189.25M
As of 2025-12-31
$156.53M
As of 2026-06-30
+58.4%
3-year compound annual growth
+37.1%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $189.25M | +45.1% | 2026-03-04, Balance as of period end |
| 2024-12-31 | $130.43M | +83.2% | 2026-03-04, Balance as of period end |
| 2023-12-31 | $71.19M | +49.4% | 2025-03-20, Balance as of period end |
| 2022-12-31 | $47.66M | +125.8% | 2024-03-14, Balance as of period end |
| 2021-12-31 | $21.10M | -46.0% | 2023-03-14, Balance as of period end |
| 2020-12-31 | $39.08M | -71.7% | 2022-03-28, Balance as of period end |
| 2019-12-31 | $137.87M | -9.9% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $152.94M | +376.3% | 2020-03-11, Balance as of period end |
| 2017-12-31 | $32.11M | +183.3% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $11.33M | n/a | 2018-03-13, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Verastem, Inc. (VSTM) | 2025-12-31 | $189.25M | +45.1% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $306.60M | -7.0% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $11.64M | -0.5% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $15.78M | +7.4% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $22.39M | -65.0% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| Celularity Inc (CELU) | 2025-12-31 | $145.39M | +17.4% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $7.04M | -0.3% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $6.64M | -34.4% |
Compare VSTM, FHTX, ZOMDF, CUE side by side · Screen every company in Pharmaceutical Preparations ↗